Document is current
Any future updates will be listed below
-
Authors
Smith, Edward https://orcid.org/0000-0002-1055-2947
Langdon, Dawn https://orcid.org/0000-0003-1128-7417
- License Information
-
More Information
Article History
Received: 27 March 2025
Accepted: 22 July 2025
First Online: 13 August 2025
Declarations
:
: Edward Smith declares no conflict of interest. Dawn Langdon has received grants, consultancy and speaker bureau honoraria from Bayer, Novartis, Merck, Roche, TEVA, Sanofi, Celgene, BMS and Biogen. Dawn Langdon is an Editorial Board member of Neurology and Therapy. Dawn Langdon was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: This study was performed in line with The Code of Ethics of the World Medical Association (Declaration of Helsinki, 1964). Ethical approval for the study was granted by the Royal Holloway University Research Ethics Committee (Research Ethics Committee Project ID: 2532). Implied informed consent for participation and data publication were obtained. This was in accordance with guidelines stipulated in the British Psychological Society’s Code of Human Research Ethics [] concerning studies obtaining anonymised-at-source non-sensitive data and underwent ethical review and approval prior to the study. Participants were aware their responses were for research.
